| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/15/2004 | US20040071710 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 04/15/2004 | US20040071706 An antibody for treating Crohn's disease and ulcerative colitis, inhibit the transduction of biological activity of cytokine, B-cell differentiation factors |
| 04/15/2004 | US20040071701 Nerve growth factor antagonist for treating pain caused by physiological disorder, no side effects |
| 04/15/2004 | US20040071699 An antagonists, or agonists, producing antibodies, used as immunotherapy treating allergy, acquired immune deficiency syndrome, autoimmune diabetes, thyroiditis |
| 04/15/2004 | US20040071698 Human anti-epidermal growth factor receptor single-chain antibodies |
| 04/15/2004 | US20040071697 Reducing epithelial toxicity during cancer therapy |
| 04/15/2004 | US20040071681 Administering 5-hydroxytryptophan in substance similar to desired consumable |
| 04/15/2004 | US20040071663 Pesticidal and antiparasitic compositions |
| 04/15/2004 | US20040071656 Modulation of heat-shock-protein-based immunotherapies |
| 04/15/2004 | US20040071654 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic |
| 04/15/2004 | DE4325927B4 Taxol enthaltender Medikamentierungskit Taxol-containing Medikamentierungskit |
| 04/15/2004 | CA2516547A1 Drug delivery device having coated microprojections incorporating vasoconstrictors |
| 04/15/2004 | CA2509526A1 Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| 04/15/2004 | CA2500904A1 Composition containing eosinophil cationic protein |
| 04/15/2004 | CA2500729A1 Synergistic methods and compositions for treating cancer |
| 04/15/2004 | CA2500714A1 Synergistic methods and compositions for treating cancer |
| 04/15/2004 | CA2500259A1 Potent inhibitor of hcv serine protease |
| 04/15/2004 | CA2498555A1 Combination chemotherapy with dehydroequol and selected chemotherapeutic agents |
| 04/14/2004 | EP1407785A1 Medicinal compositions |
| 04/14/2004 | EP1407784A1 Antitumor agents |
| 04/14/2004 | EP1407775A1 Medical preparation for parenteral injection |
| 04/14/2004 | EP1407770A1 Tgf-beta superfamily production/secretion promoter |
| 04/14/2004 | EP1407768A2 The potassium channel opener retigabine for the treatment of diseases |
| 04/14/2004 | EP1407261A1 In vivo bioreactors |
| 04/14/2004 | EP1407044A2 Rna interference mediating small rna molecules |
| 04/14/2004 | EP1407043A2 Gamma-secretase in vitro screening assay |
| 04/14/2004 | EP1407013A1 Mutations in ion channels |
| 04/14/2004 | EP1407010A1 Regulation of human aminopeptidase n |
| 04/14/2004 | EP1406928A1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 04/14/2004 | EP1406922A2 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 04/14/2004 | EP1406908A1 Morpholine-bridged pyrazolopyridine derivatives |
| 04/14/2004 | EP1406899A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 04/14/2004 | EP1406889A2 Interaction inhibitors of tcf-4 with beta-catenin |
| 04/14/2004 | EP1406872A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1406700A1 Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 04/14/2004 | EP1406696A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 04/14/2004 | EP1406682A1 Drug delivery devices |
| 04/14/2004 | EP1406664A2 Targeting chemical compounds to cells |
| 04/14/2004 | EP1406661A1 Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects |
| 04/14/2004 | EP1406660A1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor |
| 04/14/2004 | EP1406659A1 Pharmaceutical agents containing acyclovir, fusaric acid and derivatives thereof |
| 04/14/2004 | EP1406653A2 T cell regulatory genes and methods of use thereof |
| 04/14/2004 | EP1406648A1 The use of angiotensin i derivative as an agent for the treatment and prevention of infarction-related cardiac injuries and disorders |
| 04/14/2004 | EP1406639A2 Method for enhancing the effectiveness of cancer therapies |
| 04/14/2004 | EP1406633A1 Enhanced drug delivery in transdermal systems |
| 04/14/2004 | EP1406629A1 Method for inducing analgesia comprising administration alternatively of an opioid receptor agonist and an opioid receptor like receptor 1 agonist for and an implantable infusion pump |
| 04/14/2004 | EP1406622A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1406621A2 Compositions and methods for inhibiting platelet activation and thrombosis |
| 04/14/2004 | EP1406609A2 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/14/2004 | EP1406608A2 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 04/14/2004 | EP1406600A1 Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases |
| 04/14/2004 | EP1406599A1 Cosmetic and dermatological preparations containing creatine for treating and actively preventing dry skin and other negative alterations of the physiological homeostasis of healthy skin |
| 04/14/2004 | EP1406514A1 Enteral formulations |
| 04/14/2004 | EP1218063B1 Pharmaceutical composition containing trichloroacetic acid, 2-oh benzoic acid and menthol for topical application and process for the preparation thereof |
| 04/14/2004 | EP1214312B1 5-aminoalkyl and 5-aminocarbonyl substituted indoles |
| 04/14/2004 | EP0839041B1 Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 04/14/2004 | CN1489590A Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
| 04/14/2004 | CN1489576A Cannabinod receptor ligands |
| 04/14/2004 | CN1489476A Method of preparing biological materials and preparation produced using same |
| 04/14/2004 | CN1489475A preventives or remedies for endometeriosis |
| 04/14/2004 | CN1489473A Silensed anti-CD 28 antibodies and use thereof |
| 04/14/2004 | CN1489470A Use of adenosine A3 receptor agonist for inhibition of viral replication |
| 04/14/2004 | CN1489469A Medicine for lung cnncer |
| 04/14/2004 | CN1489467A Pharmacentical formulation comprising pyrazolo[4,3-d] pyrimdine and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists |
| 04/14/2004 | CN1488402A Novel medicinal use of proteinase inhibior for preventing and curing lang disease |
| 04/14/2004 | CN1488401A Use of preparing medicine for treating respiratory and cyclic failure |
| 04/14/2004 | CN1145619C 1-4-benzothiazepine derivatives methods for preparation, medicaments containing same and use thereof |
| 04/13/2004 | US6720427 Used to treat abnormal cell growth and central nervous system disorders |
| 04/13/2004 | US6720348 For therapy of diabetic neuropathy, diabetic nephropathy, diabetic cardiomyopathy, diabetic retinopathy, diabetic microangiopathy, diabetic macroangiopathy, cataracts and foot ulcers |
| 04/13/2004 | US6720340 Nicotine receptor agonists in stem cell and progenitor cell recruitment |
| 04/13/2004 | US6720337 Antitumor agents; synergistic mixtures; side effect reduction |
| 04/13/2004 | US6720332 Oxindole derivatives |
| 04/13/2004 | US6720328 Treating allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) |
| 04/13/2004 | US6720318 Combination of cyamemazine and an atypical neuroleptic |
| 04/13/2004 | US6720306 Drug delivery, antitumor agents |
| 04/13/2004 | US6720181 Ubiquitin ligases as therapeutic targets |
| 04/13/2004 | US6720013 Insect repellant-containing mineral supplement |
| 04/13/2004 | US6719996 Galenic composition for low bioavailability medicaments |
| 04/13/2004 | US6719805 Devices and methods for treating tissue |
| 04/13/2004 | US6719750 Non-linear (coil or z-shaped) body member body housing one or more substances and a delivery mechanism for the sustained delivery of the one or more substances from the non-linear shaped body member to the patient |
| 04/13/2004 | US6719540 C3-cyano epothilone derivatives |
| 04/13/2004 | CA2147123C Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo |
| 04/10/2004 | CA2445212A1 Treatment of sexual dysfunction |
| 04/08/2004 | WO2004029025A2 Methods and compositions for the treatment of autoimmune disorders using clofarabine |
| 04/08/2004 | WO2004028634A1 Method and composition for treating alzheimer's disease and dementias of vascular origin |
| 04/08/2004 | WO2004028546A1 Cholesterol efflux and uses thereof |
| 04/08/2004 | WO2004028545A1 A COMBINATION OF A LONG-ACTING β2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES |
| 04/08/2004 | WO2004028524A1 Combination drug |
| 04/08/2004 | WO2004028521A2 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders |
| 04/08/2004 | WO2004028518A1 Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set |
| 04/08/2004 | WO2004028502A1 Cleansing composition containing antifungal agent and antibacterial agent |
| 04/08/2004 | WO2004028479A2 Nouvelles compositions et methodes de traitement du psoriasis |
| 04/08/2004 | WO2004028473A2 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/08/2004 | WO2004028470A2 Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation |
| 04/08/2004 | WO2004028468A2 Methods and compositions for treatment of neurological disorder |
| 04/08/2004 | WO2004028466A2 Ketoamide inhibitors in chronic nerve disease |
| 04/08/2004 | WO2004028460A2 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
| 04/08/2004 | WO2004028456A2 Method and composition for treating neurodegenerative disorders |
| 04/08/2004 | WO2004028455A2 Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| 04/08/2004 | WO2004028453A2 Methods for preventing and treating obesity in patients with mc4 receptor mutations |